The center, led by Chuan He, PhD, a professor in the department of chemistry at University of Chicago, will create new technologies to study how RNA is regulated by chemical modifications inside cells. Researchers will work to manipulate RNA modifications, in an effort to observe their effects on RNA metabolism and gene expression.
Ultimately, this focus on RNA modifications will be used to inform research on disease development, including neurological disorders and cancer. The center will also collaborate with researchers from Baltimore-based Johns Hopkins University and Atlanta-based Emory University to apply the center’s technologies to studies of neurodevelopment and neurogenesis.
More articles on health IT:
AMA voices support for ONC’s Health IT Certification Program
Survey: physicians say mobile technology has changed hospital visits
Tempus, University of Michigan partner for personalized cancer care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
